Your browser doesn't support javascript.
loading
Identification and characterization of novel enhanced cell penetrating peptides for anti-cancer cargo delivery.
Zhang, Xiguang; Brossas, Jean Yves; Parizot, Christophe; Zini, Jean Marc; Rebollo, Angelita.
Afiliación
  • Zhang X; CIMI Paris, Inserm 1135, UPMC, 75013 Paris, France.
  • Brossas JY; CIMI Paris, Inserm 1135, UPMC, 75013 Paris, France.
  • Parizot C; Hôpital Pitié Salpêtrière, AP-HP, Department of Immunology, 75013 Paris, France.
  • Zini JM; Hôpital Pitié Salpêtrière, AP-HP, Department of Immunology, 75013 Paris, France.
  • Rebollo A; Hôpital Saint Louis, AP HP, 75010 Paris, France.
Oncotarget ; 9(5): 5944-5957, 2018 Jan 19.
Article en En | MEDLINE | ID: mdl-29464046
Cell penetrating peptides (CPP) are able cross the membrane and to transport cargos, presenting a great potential in drug delivery and diagnosis. In this paper, we have identified novel natural or synthetic CPPs. We have validated their rapid and efficient time and dose-dependent penetration, the absence of toxicity, the intracellular localization and the stability to proteases degradation, one of the main bottlenecks of peptides. Moreover, we have associate a cargo (an interfering peptide blocking the association of the serine/threonine phosphatase PP2A to its inhibitor, the oncogene SET) to the new generated shuttles and showed that they new bi-functional peptides keep the original properties of the shuttle and, in addition, are able to induce apoptosis due to the properties of the cargo. The CPPs identified in this study have promising perspectives for future anti-cancer drug delivery.
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Diagnostic_studies Idioma: En Revista: Oncotarget Año: 2018 Tipo del documento: Article País de afiliación: Francia

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Diagnostic_studies Idioma: En Revista: Oncotarget Año: 2018 Tipo del documento: Article País de afiliación: Francia